HYBRID EVENT: You can participate in person at Orlando, Florida, USA or Virtually from your home or work.
Nanotechnology in Diabetes Treatment
Nanotechnology has aided the development of innovative glucose testing and insulin administration mechanisms in diabetes research, which have the potential to significantly improve diabetics' quality of life. Nanomaterials, nanostructures, nanoparticle design, and their uses in humans are all part of this topic. It also provides more precise information for diabetes mellitus diagnosis. Nanoparticles are being developed as contrast agents to aid in the early detection of type 1 diabetes, and numerous formulations have been evaluated in human clinical trials. In the hopes of developing a cure for type 1 diabetes, nanotechnology is being employed to assist engineers create more effective vaccines.
- Nanovaccines
- Nanosensors
- Nanomedicine
Committee Members
Bob Esquerre
Esquerre Fitness Group International, United States
F Buck Willis
IUHS School of Medicine, Saint Kitts and Nevis
Wan Rosli Wan Ishak
Universiti Sains Malaysia, MalaysiaSubmit your abstract Today
Title : Does winter melon (benincasa hispida) improves nutritional values and ameliorating glycaemic parameters?
Wan Rosli Wan Ishak, Universiti Sains Malaysia, Malaysia
Title : Effect of a community-based health behaviour intervention on health-related quality of life in people with type 2 diabetes in Nepal: a cluster randomized controlled trial
Ashmita Karki, Central Queensland University, Australia
Title : Microalbuminuria and its correlation with HbA1c levels in newly diagnosed type 2 diabetics: a cross-sectional study
Sammon Khan Tareen, University Hospitals Birmingham, United Kingdom
Title : The Menopausal Mind: Reframing female senescence as a neuroendocrine disorder with root cause management strategies
Amy Gutman, AdventHealth; Tough Love MD, United States
Title : Effect of BASNEF- based Nutrition education on nutritional behaviors among elderly people and mini nutritional assessment(MNA) on nutritional status in elderly with diabetes with Type 2 diabetes (A clinical trial intervention)
Davoud Shojaeizadeh, Tehran University of Medical Sciences, Iran (Islamic Republic of)
Title : Association of Autoimmune Pathologies withType1 Diabetes: Epidemiological, clinical and metabolic aspects
Touzani Asmae, chu-Children's hospital, Morocco